| Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy M Badarni, M Prasad, N Balaban, J Zorea, KM Yegodayev, BZ Joshua, ... JCI insight 4 (8), 2019 | 54 | 2019 |
| Bis (3, 5-diiodo-2, 4, 6-trihydroxyphenyl) squaraine photodynamic therapy disrupts redox homeostasis and induce mitochondria-mediated apoptosis in human breast cancer cells PS Saneesh Babu, PM Manu, TJ Dhanya, P Tapas, RN Meera, ... Scientific reports 7 (1), 42126, 2017 | 54 | 2017 |
| TGF-beta-activated cancer-associated fibroblasts limit cetuximab efficacy in preclinical models of head and neck cancer KM Yegodayev, O Novoplansky, A Golden, M Prasad, L Levin, ... Cancers 12 (2), 339, 2020 | 43 | 2020 |
| IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer J Zorea, M Prasad, L Cohen, N Li, R Schefzik, S Ghosh, B Rotblat, B Brors, ... Cell death & disease 9 (10), 944, 2018 | 43 | 2018 |
| Graphene quantum dots decorated with boron dipyrromethene dye derivatives for photodynamic therapy S Mangalath, PS Saneesh Babu, RR Nair, PM Manu, S Krishna, SA Nair, ... ACS Applied Nano Materials 4 (4), 4162-4171, 2021 | 35 | 2021 |
| The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells M Varon, T Levy, G Mazor, H Ben David, R Marciano, Y Krelin, M Prasad, ... International Journal of Cancer 145 (12), 3402-3413, 2019 | 27 | 2019 |
| MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer O Novoplansky, M Fury, M Prasad, K Yegodayev, J Zorea, L Cohen, ... International journal of cancer 145 (3), 748-762, 2019 | 26 | 2019 |
| MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer M Prasad, J Zorea, S Jagadeeshan, AB Shnerb, S Mathukkada, ... Journal for ImmunoTherapy of Cancer 10 (3), 2022 | 25 | 2022 |
| Tumor tissue explant culture of patient-derived xenograft as potential prioritization tool for targeted therapy S Ghosh, M Prasad, K Kundu, L Cohen, KM Yegodayev, J Zorea, ... Frontiers in Oncology 9, 17, 2019 | 25 | 2019 |
| An ex vivo evaluation of the efficacy of andrographolide in modulating differential expression of transcription factors and target genes in periodontal cells and its potential … R Ambili, P Janam, PSS Babu, M Prasad, D Vinod, PRA Kumar, ... Journal of ethnopharmacology 196, 160-167, 2017 | 24 | 2017 |
| Differential expression of transcription factors NF-κB and STAT3 in periodontal ligament fibroblasts and gingiva of healthy and diseased individuals R Ambili, P Janam, PSS Babu, M Prasad, D Vinod, PRA Kumar, ... Archives of oral biology 82, 19-26, 2017 | 20 | 2017 |
| High-throughput screening identified compounds sensitizing tumor cells to glucose starvation in culture and VEGF inhibitors in vivo R Marciano, M Prasad, T Ievy, S Tzadok, G Leprivier, M Elkabets, ... Cancers 11 (2), 156, 2019 | 17 | 2019 |
| Adaptive responses to monotherapy in head and neck cancer: interventions for rationale-based therapeutic combinations S Jagadeeshan, M Prasad, S Ortiz-Cuaran, V Gregoire, P Saintigny, ... Trends in Cancer 5 (6), 365-390, 2019 | 14 | 2019 |
| Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial JL Vos, B Burman, S Jain, CWR Fitzgerald, EJ Sherman, LA Dunn, ... Nature medicine 29 (12), 3077-3089, 2023 | 9 | 2023 |
| Rapid response to the combination of lenvatinib and pembrolizumab in patients with advanced carcinomas (Lung adenocarcinoma and malignant pleural mesothelioma) W Shalata, M Iraqi, B Bhattacharya, V Fuchs, LC Roisman, AY Cohen, ... Cancers 13 (14), 3630, 2021 | 9 | 2021 |
| Mutated HRAS activates YAP1–AXL signaling to drive metastasis of head and neck cancer S Jagadeeshan, M Prasad, M Badarni, T Ben-Lulu, VB Liju, ... Cancer research 83 (7), 1031-1047, 2023 | 8 | 2023 |
| IGF2 mediates resistance to isoform-selective-inhibitors of the PI3K in HPV positive head and neck cancer M Badarni, M Prasad, A Golden, B Bhattacharya, L Levin, KM Yegodayev, ... Cancers 13 (9), 2250, 2021 | 8 | 2021 |
| Oncogenic actions of SKP2 involves deregulation of CDK1 turnover mediated by FOXM1 A Krishnan, D K, S Babu PS, S Jagadeeshan, M Prasad, SA Nair Journal of cellular biochemistry 118 (4), 797-807, 2017 | 8 | 2017 |
| Quaternized starch-based composite nanoparticles for siRNA delivery to tumors E Amar-Lewis, N Buaron, R Chintakunta, C Benafsha, R Goldbart, ... ACS Applied Nano Materials 4 (2), 2218-2229, 2021 | 7 | 2021 |
| Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer T Pradhan, K Padmanabhan, M Prasad, K Chandramohan, SA Nair Journal of cellular and molecular medicine 23 (6), 3984-3994, 2019 | 7 | 2019 |
Moshe ElkabetsProf. at the Ben-Gurion University of the NegevVerified email at bgu.ac.il
